In the last trading session, 1.03 million ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) shares changed hands as the company’s beta touched 0.20. With the company’s per share price at $0.47 changed hands at $0.02 or 2.85% during last session, the market valuation stood at $14.45M. IPA’s last price was a discount, traded about -453.19% off its 52-week high of $2.60. The share price had its 52-week low at $0.32, which suggests the last value was 31.91% up since then. When we look at ImmunoPrecise Antibodies Ltd’s average trading volume, we note the 10-day average is 35.57 million shares, with the 3-month average coming to 6.14 million.
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) trade information
Instantly IPA was in green as seen at the end of in last trading. With action -19.31%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 12.99%, with the 5-day performance at -19.31% in the red. However, in the 30-day time frame, ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) is 13.74% up. Looking at the short shares, we see there were 0.69 million shares sold at short interest cover period of 0.7 days.
ImmunoPrecise Antibodies Ltd (IPA) estimates and forecasts
Data shows that the ImmunoPrecise Antibodies Ltd share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -41.04% over the past 6 months, a 65.38% in annual growth rate that is considerably higher than the industry average of 24.70%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -11.23%. The 2025 estimates are for ImmunoPrecise Antibodies Ltd earnings to increase by 62.22%.
IPA Dividends
ImmunoPrecise Antibodies Ltd is expected to release its next quarterly earnings report in March.
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 12.06% of ImmunoPrecise Antibodies Ltd shares while 6.58% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 7.48%. There are 6.58% institutions holding the ImmunoPrecise Antibodies Ltd stock share, with INGALLS & SNYDER LLC the top institutional holder. As of 2024-06-30, the company held 5.0209% of the shares, roughly 1.3 million IPA shares worth $1.31 million.
RENAISSANCE TECHNOLOGIES LLC holds the second largest percentage of outstanding shares, with 0.2477% or 63910.0 shares worth $64549.0 as of 2024-06-30.
With 17.48 shares estimated at $8133.0 under it, the former controlled 0.06% of total outstanding shares.
